{"id":2117,"date":"2026-09-07T16:16:46","date_gmt":"2026-09-07T14:16:46","guid":{"rendered":"https:\/\/www.amyloidosisalliance.org\/klinische-studien\/"},"modified":"2026-10-21T17:37:49","modified_gmt":"2026-10-21T15:37:49","slug":"klinische-studien","status":"publish","type":"page","link":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/","title":{"rendered":"Klinische Studien"},"content":{"rendered":"\n<nav aria-label=\"Breadcrumb\" class=\"wp-block-group aa-breadcrumb is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"aa-inner\"><a href=\"https:\/\/www.amyloidosisalliance.org\/de\/\">Startseite<\/a><span class=\"aa-breadcrumb__sep\">\u203a<\/span><span class=\"aa-breadcrumb__current\">Klinische Studien<\/span><\/div>\n<\/nav>\n\n<section class=\"wp-block-group aa-page-hero is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-page-hero__grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-overline wp-block-paragraph\">Forschung<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Klinische Studien<\/h1>\n\n\n\n<p class=\"aa-lead wp-block-paragraph\">Alle Studien zu Amyloidose, die derzeit rekrutieren, bald starten oder Teilnehmende auf Einladung aufnehmen, weltweit, direkt aus ClinicalTrials.gov und t\u00e4glich aktualisiert.<\/p>\n\n\n\n<p class=\"aa-trial-warn wp-block-paragraph\"><strong>Eine Information, keine \u00e4rztliche Beratung.<\/strong> Die Allianz f\u00fchrt diese Studien nicht durch und kann Sie nicht f\u00fcr eine Teilnahme anmelden. Wenn Ihnen eine Studie relevant erscheint, besprechen Sie sie mit dem Arzt, der Ihre Amyloidose behandelt.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-page-hero__photo is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1707\" height=\"1707\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\" alt=\"\" class=\"wp-image-1000\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg 1707w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-1024x1024.jpg 1024w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-150x150.jpg 150w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-768x768.jpg 768w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-1536x1536.jpg 1536w\" sizes=\"auto, (max-width: 1707px) 100vw, 1707px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section id=\"trials\" class=\"wp-block-group aa-section aa-section--cream aa-trials-page is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading\">Rekrutierende und bevorstehende Studien<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Die Liste umfasst die AL-, ATTR- und AA-Amyloidose sowie die zerebrale Amyloidangiopathie. Jede Karte zeigt, wo die Studie steht: offen f\u00fcr alle, die ihre Kriterien erf\u00fcllen, noch nicht ge\u00f6ffnet oder auf Personen beschr\u00e4nkt, die von den Pr\u00fcf\u00e4rzten eingeladen werden. Abgeschlossene Studien verschwinden einfach aus der Liste.<\/p>\n\n\n<div class=\"aa-trials aa-no-reveal wp-block-aa-clinical-trials\" data-endpoint=\"https:\/\/www.amyloidosisalliance.org\/de\/wp-json\/aa\/v1\/trials\" data-page=\"0\" data-per-page=\"12\"><form class=\"aa-trial-filters\" method=\"get\" action=\"https:\/\/www.amyloidosisalliance.org\/de\/\"><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_type\">Art der Amyloidose<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_type\" name=\"t_type\"><option value=\"\">Alle Arten<\/option><option value=\"attr\">ATTR (Transthyretin)<\/option><option value=\"al\">AL (Leichtketten)<\/option><option value=\"aa\">AA (sekund\u00e4r)<\/option><option value=\"caa\">Zerebrale Amyloidangiopathie<\/option><option value=\"unspecified\">Nicht angegeben<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_country\">Land<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_country\" name=\"t_country\"><option value=\"\">Alle L\u00e4nder<\/option><option value=\"Argentina\">Argentina<\/option><option value=\"Australia\">Australia<\/option><option value=\"Austria\">Austria<\/option><option value=\"Belgium\">Belgium<\/option><option value=\"Brazil\">Brazil<\/option><option value=\"Bulgaria\">Bulgaria<\/option><option value=\"Canada\">Canada<\/option><option value=\"Chile\">Chile<\/option><option value=\"China\">China<\/option><option value=\"Croatia\">Croatia<\/option><option value=\"Cyprus\">Cyprus<\/option><option value=\"Czechia\">Czechia<\/option><option value=\"Denmark\">Denmark<\/option><option value=\"Estonia\">Estonia<\/option><option value=\"Finland\">Finland<\/option><option value=\"France\">France<\/option><option value=\"Germany\">Germany<\/option><option value=\"Greece\">Greece<\/option><option value=\"Hong Kong\">Hong Kong<\/option><option value=\"Hungary\">Hungary<\/option><option value=\"Ireland\">Ireland<\/option><option value=\"Israel\">Israel<\/option><option value=\"Italy\">Italy<\/option><option value=\"Japan\">Japan<\/option><option value=\"Latvia\">Latvia<\/option><option value=\"Lithuania\">Lithuania<\/option><option value=\"Malaysia\">Malaysia<\/option><option value=\"Martinique\">Martinique<\/option><option value=\"Mexico\">Mexico<\/option><option value=\"Netherlands\">Netherlands<\/option><option value=\"New Zealand\">New Zealand<\/option><option value=\"Norway\">Norway<\/option><option value=\"Poland\">Poland<\/option><option value=\"Portugal\">Portugal<\/option><option value=\"Romania\">Romania<\/option><option value=\"Singapore\">Singapore<\/option><option value=\"Slovakia\">Slovakia<\/option><option value=\"Slovenia\">Slovenia<\/option><option value=\"South Korea\">South Korea<\/option><option value=\"Spain\">Spain<\/option><option value=\"Sweden\">Sweden<\/option><option value=\"Switzerland\">Switzerland<\/option><option value=\"Taiwan\">Taiwan<\/option><option value=\"Thailand\">Thailand<\/option><option value=\"Turkey (T\u00fcrkiye)\">Turkey (T\u00fcrkiye)<\/option><option value=\"United Kingdom\">United Kingdom<\/option><option value=\"United States\">United States<\/option><option value=\"Uruguay\">Uruguay<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_kind\">Studientyp<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_kind\" name=\"t_kind\"><option value=\"\">Alle Studien<\/option><option value=\"INTERVENTIONAL\">Interventionell (Behandlung)<\/option><option value=\"OBSERVATIONAL\">Beobachtend (Register, Bildgebung)<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_status\">Status<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_status\" name=\"t_status\"><option value=\"\">Alle Status<\/option><option value=\"RECRUITING\">Rekrutierend<\/option><option value=\"NOT_YET_RECRUITING\">Noch nicht rekrutierend<\/option><option value=\"ENROLLING_BY_INVITATION\">Nur auf Einladung<\/option><\/select><\/p><p class=\"aa-trial-filters__actions\"><button type=\"submit\" class=\"aa-trial-filters__submit\">Filtern<\/button><a class=\"aa-trial-filters__reset\" href=\"https:\/\/www.amyloidosisalliance.org\/de\/\" hidden>Filter zur\u00fccksetzen<\/a><\/p><\/form><div class=\"aa-trial-results\" aria-live=\"polite\" aria-busy=\"false\"><p class=\"aa-trial-count\">1 bis 12 von 207 Studien<\/p><div class=\"aa-trial-grid\"><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--not-yet-recruiting\">Noch nicht rekrutierend<\/span><span class=\"aa-trial-type\">ATTR (Transthyretin)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07538518\" target=\"_blank\" rel=\"noopener noreferrer\">PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The goal of this study is to learn whether PET-CT imaging using evuzamitide can help diagnose transthyretin cardiac amyloidosis (ATTR-CA) in patients whose standard\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Beobachtend (Register, Bildgebung)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Lorena Saelices<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07538518<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 22. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--enrolling-by-invitation\">Nur auf Einladung<\/span><span class=\"aa-trial-type\">ATTR (Transthyretin)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06679946\" target=\"_blank\" rel=\"noopener noreferrer\">A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to obtain safety, efficacy, and pharmacodynamic data on the use of vutrisiran in patients with ATTR amyloidosis with\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventionell (Behandlung)<\/dd><\/div><div><dt>Phase<\/dt><dd>Phase 3<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Alnylam Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Argentina<\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">Brazil<\/span><span class=\"aa-trial-place aa-trial-place--more\">+13<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT06679946<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 21. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">ATTR (Transthyretin)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07207811\" target=\"_blank\" rel=\"noopener noreferrer\">CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventionell (Behandlung)<\/dd><\/div><div><dt>Phase<\/dt><dd>Phase 3<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Novo Nordisk A\/S<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Argentina<\/span><span class=\"aa-trial-place\">Australia<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">Brazil<\/span><span class=\"aa-trial-place aa-trial-place--more\">+16<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07207811<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 21. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--not-yet-recruiting\">Noch nicht rekrutierend<\/span><span class=\"aa-trial-type\">AL (Leichtketten)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07874334\" target=\"_blank\" rel=\"noopener noreferrer\">Phase 1a\/b Study of GPRC5D CART Therapy in Relapsed\/Refractory Multiple Myeloma and Light-chain Amyloidosis<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">A Phase 1a\/b Open-Label Study to Evaluate Safety and Preliminary Efficacy of GPRC5D CART Therapy for the Treatment of Relapsed\/Refractory Multiple Myeloma and Light-chain\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventionell (Behandlung)<\/dd><\/div><div><dt>Phase<\/dt><dd>Phase 1<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Hadassah Medical Organization<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Israel<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07874334<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 20. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">ATTR (Transthyretin)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07052903\" target=\"_blank\" rel=\"noopener noreferrer\">TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to: * Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventionell (Behandlung)<\/dd><\/div><div><dt>Phase<\/dt><dd>Phase 3<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Alnylam Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Argentina<\/span><span class=\"aa-trial-place\">Australia<\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place aa-trial-place--more\">+32<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07052903<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 20. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">ATTR (Transthyretin)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07298044\" target=\"_blank\" rel=\"noopener noreferrer\">A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">Transthyretin (TTR) is a protein made by the liver that helps transport thyroid hormone and vitamin A in the blood. In some people, this\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventionell (Behandlung)<\/dd><\/div><div><dt>Phase<\/dt><dd>Phase 4<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Bayer<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">Germany<\/span><span class=\"aa-trial-place\">Italy<\/span><span class=\"aa-trial-place aa-trial-place--more\">+1<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07298044<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 15. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">ATTR (Transthyretin)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04561518\" target=\"_blank\" rel=\"noopener noreferrer\">ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to: * Describe epidemiological and clinical characteristics, natural history and real-world clinical management of ATTR amyloidosis patients *\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Beobachtend (Register, Bildgebung)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Alnylam Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Brazil<\/span><span class=\"aa-trial-place\">Bulgaria<\/span><span class=\"aa-trial-place\">Denmark<\/span><span class=\"aa-trial-place\">France<\/span><span class=\"aa-trial-place aa-trial-place--more\">+8<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT04561518<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 13. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">Nicht angegeben<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07583823\" target=\"_blank\" rel=\"noopener noreferrer\">Elevated Rate Pacing of Cardiac Amyloidosis<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventionell (Behandlung)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>University of Minnesota<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07583823<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 13. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">ATTR (Transthyretin)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07358078\" target=\"_blank\" rel=\"noopener noreferrer\">DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to: * Describe the clinical characteristics of adult patients with transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM) treated with vutrisiran\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Beobachtend (Register, Bildgebung)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Alnylam Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Germany<\/span><span class=\"aa-trial-place\">Japan<\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07358078<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 9. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">Nicht angegeben<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07589595\" target=\"_blank\" rel=\"noopener noreferrer\">A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventionell (Behandlung)<\/dd><\/div><div><dt>Phase<\/dt><dd>Phase 2<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Eli Lilly and Company<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Japan<\/span><span class=\"aa-trial-place\">South Korea<\/span><span class=\"aa-trial-place\">Taiwan<\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07589595<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 8. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">ATTR (Transthyretin)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07235462\" target=\"_blank\" rel=\"noopener noreferrer\">A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a serious and life-threatening condition where a protein called transthyretin (TTR) misfolds and builds up as amyloid fibrils in\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Beobachtend (Register, Bildgebung)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>Bayer<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">Croatia<\/span><span class=\"aa-trial-place\">Denmark<\/span><span class=\"aa-trial-place aa-trial-place--more\">+13<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07235462<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 8. Oktober 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Rekrutierend<\/span><span class=\"aa-trial-type\">Nicht angegeben<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07494942\" target=\"_blank\" rel=\"noopener noreferrer\">Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis<span class=\"screen-reader-text\"> (\u00f6ffnet ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The goal of this clinical trial is to learn if a structured cardiac rehabilitation program can help people with cardiac amyloidosis improve their ability\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Studie<\/dt><dd>Interventionell (Behandlung)<\/dd><\/div><div><dt>Sponsor<\/dt><dd>University Hospital, Montpellier<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Rekrutiert in: <\/span><span class=\"aa-trial-place\">France<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07494942<\/span><span class=\"aa-trial-card__updated\">Aktualisiert am 8. Oktober 2026<\/span><\/p><\/article><\/div><nav class=\"aa-trial-pager\" aria-label=\"Seiten der Studienliste\"><span aria-current=\"page\" class=\"page-numbers current\">1<\/span><a class=\"page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/de\/?t_page=2\">2<\/a><span class=\"page-numbers dots\">&hellip;<\/span><a class=\"page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/de\/?t_page=18\">18<\/a><a class=\"next page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/de\/?t_page=2\">Weiter<\/a><\/nav><div class=\"aa-trial-registry\"><p class=\"aa-trial-registry__text\">Diese Liste umfasst nur Studien zur Amyloidose, die offen sind oder bald beginnen. Das Register verzeichnet alle Studien, auch bereits abgeschlossene.<\/p><div class=\"wp-block-button aa-btn aa-btn--teal\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">Alle Studien auf ClinicalTrials.gov durchsuchen<span class=\"screen-reader-text\"> (\u00f6ffnet in einem neuen Tab)<\/span><\/a><\/div><\/div><p class=\"aa-trial-source\">Quelle: ClinicalTrials.gov (U.S. National Library of Medicine). Liste zuletzt abgerufen am 22. Oktober 2026. <a href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">clinicaltrials.gov<\/a><\/p><\/div><\/div><\/div>\n<\/section>\n\n<section class=\"wp-block-group aa-section aa-section--forest aa-cta is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner aa-narrow aa-text-center is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading\">Sie wissen nicht, wo Sie anfangen sollen?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Unsere Mitgliedsorganisationen kennen die Teams, die diese Studien in ihrem Land durchf\u00fchren, und k\u00f6nnen Ihnen helfen, das Gespr\u00e4ch mit Ihrem Arzt vorzubereiten.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-aec23bef wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button aa-btn aa-btn--primary\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.amyloidosisalliance.org\/de\/mitglieder\/\">Eine Organisation in Ihrer N\u00e4he finden<\/a><\/div>\n\n\n\n<div class=\"wp-block-button aa-btn aa-btn--ghost-paper\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.amyloidosisalliance.org\/de\/kontakt\/\">Die Allianz kontaktieren<\/a><\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Startseite\u203aKlinische Studien Forschung Klinische Studien Alle Studien zu Amyloidose, die derzeit rekrutieren, bald starten oder Teilnehmende auf Einladung aufnehmen, weltweit, direkt aus ClinicalTrials.gov und t\u00e4glich aktualisiert. Eine Information, keine \u00e4rztliche Beratung. Die Allianz f\u00fchrt diese Studien nicht durch und kann Sie nicht f\u00fcr eine Teilnahme anmelden. Wenn Ihnen eine Studie relevant erscheint, besprechen Sie sie [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2117","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Klinische Studien zu Amyloidose, die weltweit rekrutieren<\/title>\n<meta name=\"description\" content=\"Alle Studien zu Amyloidose, die derzeit rekrutieren oder bald starten, aus ClinicalTrials.gov und t\u00e4glich aktualisiert. Filtern Sie nach Form, Land und Status.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Klinische Studien zu Amyloidose, die weltweit rekrutieren\" \/>\n<meta property=\"og:description\" content=\"Alle Studien zu Amyloidose, die derzeit rekrutieren oder bald starten, aus ClinicalTrials.gov und t\u00e4glich aktualisiert. Filtern Sie nach Form, Land und Status.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/\" \/>\n<meta property=\"og:site_name\" content=\"Amyloidosis Alliance\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmyloidosisAlliance\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-21T15:37:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1707\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/klinische-studien\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/klinische-studien\\\/\",\"name\":\"Klinische Studien zu Amyloidose, die weltweit rekrutieren\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/klinische-studien\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/klinische-studien\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\",\"datePublished\":\"2026-09-07T14:16:46+00:00\",\"dateModified\":\"2026-10-21T15:37:49+00:00\",\"description\":\"Alle Studien zu Amyloidose, die derzeit rekrutieren oder bald starten, aus ClinicalTrials.gov und t\u00e4glich aktualisiert. Filtern Sie nach Form, Land und Status.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/klinische-studien\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/klinische-studien\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/klinische-studien\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/klinische-studien\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/startseite\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Klinische Studien\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/\",\"name\":\"Amyloidosis Alliance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/#organization\",\"name\":\"Amyloidosis Alliance\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"width\":252,\"height\":252,\"caption\":\"Amyloidosis Alliance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmyloidosisAlliance\\\/\",\"https:\\\/\\\/x.com\\\/amyloidosisa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Klinische Studien zu Amyloidose, die weltweit rekrutieren","description":"Alle Studien zu Amyloidose, die derzeit rekrutieren oder bald starten, aus ClinicalTrials.gov und t\u00e4glich aktualisiert. Filtern Sie nach Form, Land und Status.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/","og_locale":"de_DE","og_type":"article","og_title":"Klinische Studien zu Amyloidose, die weltweit rekrutieren","og_description":"Alle Studien zu Amyloidose, die derzeit rekrutieren oder bald starten, aus ClinicalTrials.gov und t\u00e4glich aktualisiert. Filtern Sie nach Form, Land und Status.","og_url":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/","og_site_name":"Amyloidosis Alliance","article_publisher":"https:\/\/www.facebook.com\/AmyloidosisAlliance\/","article_modified_time":"2026-10-21T15:37:49+00:00","og_image":[{"width":1707,"height":1707,"url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@amyloidosisa","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/","url":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/","name":"Klinische Studien zu Amyloidose, die weltweit rekrutieren","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/#primaryimage"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/#primaryimage"},"thumbnailUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","datePublished":"2026-09-07T14:16:46+00:00","dateModified":"2026-10-21T15:37:49+00:00","description":"Alle Studien zu Amyloidose, die derzeit rekrutieren oder bald starten, aus ClinicalTrials.gov und t\u00e4glich aktualisiert. Filtern Sie nach Form, Land und Status.","breadcrumb":{"@id":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/#primaryimage","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.amyloidosisalliance.org\/de\/klinische-studien\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.amyloidosisalliance.org\/de\/startseite\/"},{"@type":"ListItem","position":2,"name":"Klinische Studien"}]},{"@type":"WebSite","@id":"https:\/\/www.amyloidosisalliance.org\/de\/#website","url":"https:\/\/www.amyloidosisalliance.org\/de\/","name":"Amyloidosis Alliance","description":"","publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.amyloidosisalliance.org\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.amyloidosisalliance.org\/de\/#organization","name":"Amyloidosis Alliance","url":"https:\/\/www.amyloidosisalliance.org\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.amyloidosisalliance.org\/de\/#\/schema\/logo\/image\/","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","width":252,"height":252,"caption":"Amyloidosis Alliance"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmyloidosisAlliance\/","https:\/\/x.com\/amyloidosisa"]}]}},"_links":{"self":[{"href":"https:\/\/www.amyloidosisalliance.org\/de\/wp-json\/wp\/v2\/pages\/2117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amyloidosisalliance.org\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.amyloidosisalliance.org\/de\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/de\/wp-json\/wp\/v2\/comments?post=2117"}],"version-history":[{"count":1,"href":"https:\/\/www.amyloidosisalliance.org\/de\/wp-json\/wp\/v2\/pages\/2117\/revisions"}],"predecessor-version":[{"id":2118,"href":"https:\/\/www.amyloidosisalliance.org\/de\/wp-json\/wp\/v2\/pages\/2117\/revisions\/2118"}],"wp:attachment":[{"href":"https:\/\/www.amyloidosisalliance.org\/de\/wp-json\/wp\/v2\/media?parent=2117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}